CClinicalTrials.gg
CompletedNCT05376982Updated Aug 4, 2022

Comparison of NT Vs Body Weight Supported TT Along With CT on Lower Extremity in Chronic Stroke Patients

An interventional study of Neurodevelopmental Treatment and Body weight supported treadmill training along with conventional therapy in Chronic Stroke, sponsored by Superior University. Completed at 1 site in Pakistan. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2022-08-04.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Study summary

To determine the effect of Neurodevelopment Treatment vs Body Weight Supported Treadmill Training along with conventional therapy on lower extremity among chronic stroke patients.

02

Conditions studied

  • Chronic Stroke
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 42 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Application of M-Cog test for checking patients cognition.
  • Chronic ischemic stroke patients.
  • Both Male and Female Patients.
  • Patients of 35 or above years of age.

Exclusion criteria

Exclusion Criteria:

  • Patients with history of recurrent stroke.
  • Patients with lower limb fractures or dislocations.
  • Patients with Peripheral vascular disease
  • Patients with skin discoloration or skin ulcers.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Neurodevelopmental Treatment

    Using Neurodevelopmental Treatment Method

    Diagnostic Test: Neurodevelopmental Treatment

  • Experimental
    Body weight supported treadmill training along with conventional therapy

    Using Body weight supported treadmill training along with conventional therapy Method

    Diagnostic Test: Body weight supported treadmill training along with conventional therapy

Interventions

  • Diagnostic testNeurodevelopmental Treatment

    Using Neurodevelopmental Treatment Method

  • Diagnostic testBody weight supported treadmill training along with conventional therapy

    Using Body weight supported treadmill training along with conventional therapy Method

06

What researchers measure

Primary outcomes

  1. For lower extremity among chronic stroke patients

    comparison of neurodevelopmental treatment vs body weight supported treadmill training along with conventional therapy on lower extremity among chronic stroke patients

    Time frame: 6 Months

07

Study locations

1 site
  • • General Hospital. • Chaudhary Muhammad Akram Teaching and Research Hospital, University of Lahore Teaching Hospital, Shadman Medical Center, Services Hospital, Bahria International Hospital
    Lahore, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05376982
Lead sponsor
Superior University
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
May 17, 2022
Start date
Mar 31, 2022
Primary completion
Jul 13, 2022
Completion
Aug 1, 2022
Last update
Aug 4, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion